Operative management in patients with upper tract urothelial carcinoma in Iceland: a population-based study

被引:1
作者
Bjornsson, Oddur [1 ]
Jonsson, Eirikur [1 ]
Gudmundsson, Eirikur Orri [1 ]
Marteinsson, Valur Thor [2 ]
Nikulasson, Sigfus Thor [3 ]
Gudjonsson, Sigurdur [1 ]
机构
[1] Landspitali Univ Hosp, Dept Urol, IS-101 Reykjavik, Iceland
[2] Akureyri Hosp, Dept Surg, Akureyri, Iceland
[3] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland
关键词
Upper tract urothelial carcinoma; nephroureterectomy; bladder recurrence; survival; UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; BLADDER-TUMORS; PREVENTION; PREDICTORS; RECURRENCE; SURVIVAL; OUTCOMES; TRIAL;
D O I
10.1080/21681805.2021.1916073
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective Radical nephroureterectomy is the standard treatment of organ-confined upper tract urothelial carcinoma (UTUC). The objective of this study was to investigate survival and bladder recurrence rate in Icelandic patients with UTUC who underwent radical nephroureterctomy (RNU) or other procedures with curative intent. Material and methods All patients who were diagnosed with UTUC in Iceland from 2003 to 2016 and treated with curative intent were included in the study. Information on patients was obtained retrospectively from patients' medical records and from the Icelandic Cause of Death Registry. Results Overall 63 patients underwent a procedure for UTUC with curative intent in Iceland during the study period. The median age was 71 years and the majority were male (65%). In 50 patients (79%), the tumor was a primary UTUC. The most common procedure was RNU (78%) and eight patients (13%) underwent a kidney-sparing procedure. No patient died within 90 d of surgery. Twenty-eight patients (44%) had pathological stage T2 or higher, whereas 35 patients (56%) had pathological stage T1 or lower. The median follow-up time was 98.8 months . During the follow-up time 25 patients (40%) were diagnosed with recurrence in the bladder. Five-year cancer-specific survival (CSS) was 67%. Conclusions This population-based study shows that the oncologic outcome in Icelandic patients with UTUC is similar to what has been reported in other countries. Bladder recurrence rate is high and can hopefully be reduced by improvements in surgical and intravesical instillation treatment. Possibly more kidney-sparing surgeries could have been done during the study period; however, careful selection for those procedures is mandatory.
引用
收藏
页码:197 / 202
页数:6
相关论文
共 50 条
[31]   Prognostic Factors for Upper Urinary Tract Urothelial Carcinoma after Nephroureterectomy [J].
Kuroda, Kenji ;
Asakuma, Junichi ;
Horiguchi, Akio ;
Tasaki, Shinsuke ;
Yoshii, Hidehiko ;
Sato, Akinori ;
Ito, Keiichi ;
Seguchi, Kenji ;
Sumitomo, Makoto ;
Asano, Tomohiko .
UROLOGIA INTERNATIONALIS, 2012, 88 (02) :225-231
[32]   Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study [J].
Ignacio Martinez-Salamanca, Juan ;
Shariat, Shahrokh F. ;
Carballido Rodriguez, Joaquin ;
Chromecki, Thomas F. ;
Ficarra, Vincenzo ;
Fritsche, Hans-Martin ;
Kassouf, Wassim ;
Matsumoto, Kazumasa ;
Osorio Cabello, Lucia ;
Seitz, Christian ;
Tritschler, Stefan ;
Walton, Thomas J. ;
Zattoni, Filiberto ;
Novara, Giacomo .
BJU INTERNATIONAL, 2012, 109 (08) :1155-1161
[33]   Advancements in the clinical management of upper tract urothelial carcinoma [J].
Taylor, Jacob ;
Meng, Xiaosong ;
Ghandour, Rashed ;
Margulis, Vitaly .
EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (12) :1051-1060
[34]   Trends of incidence and prognosis of upper tract urothelial carcinoma [J].
Wu, Jianping ;
Chen, Shuqiu ;
Wu, Xiaoli ;
Mao, Weipu ;
Wang, Yali ;
Xu, Bin ;
Zheng, Donghui ;
Chen, Ming .
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (05) :607-619
[35]   Upper tract urothelial carcinoma: Impact of time to surgery [J].
Sundi, Debasish ;
Svatek, Robert S. ;
Margulis, Vitaly ;
Wood, Christopher G. ;
Matin, Surena F. ;
Dinney, Colin P. ;
Kamat, Ashish M. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (03) :266-272
[36]   Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis [J].
Peng, Fu-Sheng ;
Wu, Wan-Ting ;
Zhang, Lu ;
Shen, Jia-Hua ;
Yu, Dong-Dong ;
Mao, Li-Qi .
FRONTIERS IN ONCOLOGY, 2022, 12
[37]   Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy [J].
Liu, Wen ;
Wang, Zhankun ;
Liu, Shuai ;
Yao, Yu ;
Liu, Yong ;
Zhang, Guiming .
BMC CANCER, 2020, 20 (01)
[38]   A Case for Nephron Sparing Surgery in the Management of Upper Tract Urothelial Carcinoma [J].
Motamedinia, Piruz ;
Hoenig, David ;
Okeke, Zeph ;
Smith, Arthur .
JOURNAL OF ENDOUROLOGY, 2016, 30 :S18-S22
[39]   Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study [J].
Matsumoto, Kazumasa ;
Novara, Giacomo ;
Gupta, Amit ;
Margulis, Vitaly ;
Walton, Thomas J. ;
Roscigno, Marco ;
Ng, Casey ;
Kikuchi, Eiji ;
Zigeuner, Richard ;
Kassouf, Wassim ;
Fritsche, Hans-Martin ;
Ficarra, Vincenzo ;
Martignoni, Guido ;
Tritschler, Stefan ;
Carballido Rodriguez, Joaquin ;
Seitz, Christian ;
Weizer, Alon ;
Remzi, Mesut ;
Raman, Jay D. ;
Bolenz, Christian ;
Bensalah, Karim ;
Koppie, Theresa M. ;
Karakiewicz, Pierre I. ;
Wood, Christopher G. ;
Montorsi, Francesco ;
Iwamura, Masatsugu ;
Shariat, Shahrokh F. .
BJU INTERNATIONAL, 2011, 108 (8B) :E304-E309
[40]   Prognostic serum markers in patients with high-grade upper tract urothelial carcinoma [J].
Sheth, Kunj R. ;
Haddad, Ahmed Q. ;
Ashorobi, Omotola S. ;
Meissner, Matthew A. ;
Sagalowsky, Arthur I. ;
Lotan, Yair ;
Margulis, Vitaly .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (09) :418.e9-418.e16